![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-b661d4eca712bc2750cec80bcafb228c1875e1a39b2caca34f7b502b8e28c2b9.jpg)
Ozurdex for Diabetic Macular Edema: Clinical Effectiveness, Cost-effectiveness, and Guidelines
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.